Hong Kong Food Stock News

SSY Group Limited recently announced that it obtained National Medical Products Administration approval in China for its Perindopril Arginine and Amlodipine Besylate Tablets (III), a type 4 chemical drug for adult hypertension patients whose blood pressure is not adequately controlled by monotherapy. This regulatory clearance, which includes passing the consistency evaluation, adds a new fixed-dose combination hypertension therapy to SSY Group’s pharmaceutical portfolio and broadens its...

In recent days, New World Development intensified its deleveraging drive, continuing to sell assets to reduce net gearing and ease creditor concerns amid a weak Hong Kong property market. This push to slim down the balance sheet highlights how balance sheet health is becoming as important as project pipelines for major developers. We’ll now explore how this renewed focus on asset disposals and debt reduction could influence New World Development’s wider investment narrative. The end of...

At an Extraordinary General Meeting held on 29 December 2025, Sinotrans Limited approved a reduction of its registered capital and related amendments to its Articles of Association. This reshaping of the company’s legal and capital framework could influence how Sinotrans allocates resources between growth initiatives, balance sheet strength and shareholder returns. We’ll now examine how the approved registered capital reduction could influence Sinotrans’s existing investment narrative and...

Kingsoft (SEHK:3888) has renewed and expanded its cooperation framework with Xiaomi and signed a new six year lease with Xiaomi affiliate Beijing Duokan, setting out detailed terms for connected transactions and ongoing operations. See our latest analysis for Kingsoft. These renewed Xiaomi agreements land after a mixed period for investors, with a 7 day share price return of 5.98% and a 1 year total shareholder return decline of 6.12%. This suggests that near term momentum is picking up while...

Ascletis Pharma announced that it received U.S. FDA Investigational New Drug clearance for a 13-week Phase II trial of its oral small-molecule GLP-1 candidate ASC30 in type 2 diabetes, with enrollment planned to start in the first quarter of 2026. The clearance builds on prior Phase II obesity data in which ASC30 delivered dose-dependent weight loss and relatively favorable gastrointestinal tolerability, reinforcing its potential as an oral treatment option across major metabolic...

As Asia's markets continue to navigate a complex global landscape, characterized by fluctuations in major indices and mixed economic signals, investors are increasingly exploring diverse opportunities. Penny stocks, often seen as relics of past trading days, remain relevant for those seeking potential growth at lower price points. In this article, we explore three penny stocks that stand out due to their balance sheet strength and potential for significant returns, offering investors a chance...

As we enter January 2026, the Asian markets are capturing attention with a mix of optimism and caution, particularly as China's manufacturing sector shows signs of recovery and South Korea's export-driven growth continues to impress. In this dynamic environment, identifying stocks that possess strong fundamentals and potential for growth can be particularly rewarding for investors seeking opportunities in the region.

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...

From what we can see, insiders were net buyers in Minth Group Limited's ( HKG:425 ) during the past 12 months. That is...

With a price-to-sales (or "P/S") ratio of 0.7x Xuan Wu Cloud Technology Holdings Limited ( HKG:2392 ) may be sending...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

With its stock down 15% over the past three months, it is easy to disregard LEPU ScienTech Medical Technology...

AviChina Industry & Technology Company Limited ( HKG:2357 ) shareholders should be happy to see the share price up 12...

NetEase Cloud Music Inc. ( HKG:9899 ), is not the largest company out there, but it saw significant share price...

Key Insights Medlive Technology's estimated fair value is HK$8.08 based on 2 Stage Free Cash Flow to Equity Current...

CSSC (Hong Kong) Shipping Company Limited has announced a special dividend of HK$0.06 per share, with an ex-dividend date of 30 January 2026, record date of 5 February 2026 and payment on 16 March 2026, alongside board changes effective 6 January 2026. The appointment of industry veteran Mr. Xie Weizhong as a non-executive director, with deep shipbuilding experience, may reshape how investors assess the company’s governance and sector expertise. We will now examine how the special dividend...

The Trigiant Group Limited ( HKG:1300 ) share price has done very well over the last month, posting an excellent gain...

Momentum Financial Holdings Limited ( HKG:1152 ) shareholders are no doubt pleased to see that the share price has...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Zhenro Services Group fair value estimate is HK$0.13 Zhenro...

With a price-to-sales (or "P/S") ratio of 0.1x Renrui Human Resources Technology Holdings Limited ( HKG:6919 ) may be...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

There wouldn't be many who think FingerTango Inc.'s ( HKG:6860 ) price-to-earnings (or "P/E") ratio of 12.4x is worth a...

You may think that with a price-to-sales (or "P/S") ratio of 0.6x Niche-Tech Semiconductor Materials Limited ( HKG:8490...

Key Insights PCCW's estimated fair value is HK$5.16 based on 2 Stage Free Cash Flow to Equity Current share price of...